Abraham Ceesay, CEO: Rapport Therapeutics RAPP Planned sale · Filed 06/29

Trade details

Type: Planned sale notice
Stock: Rapport Therapeutics RAPP
Person: Abraham CeesayCEO
Planned sale date: 26/06/29
Filed: 26/06/29

0.2% of shares outstanding to be sold

Rapport Therapeutics trades, last 26 weeks

What else happened in Rapport Therapeutics around then

Filed or reported within 30 days of the trade day · 05/30~07/29

Abraham Ceesay's recent trades

Abraham CeesayCEO
Sell10b5-1 planRapport Therapeutics
Sell10b5-1 plan
Rapport Therapeutics
RAPP
$76.2K
1,952 sh
$76.2K
Filed 09/24
Traded 09/23
Abraham CeesayCEO
Sell10b5-1 planRapport Therapeutics
Sell10b5-1 plan
Rapport Therapeutics
RAPP
$8,570
215 sh
$8,570
Filed 09/24
Traded 09/23
Abraham CeesayCEO
Sell10b5-1 planRapport Therapeutics
Sell10b5-1 plan
Rapport Therapeutics
RAPP
$1,765
43 sh
$1,765
Filed 09/24
Traded 09/23
Abraham CeesayDirector
Planned salePacira BioSciences
Planned sale
Pacira BioSciences
PCRX
$210.4K
9,039 sh
$210.4K
Filed 06/12
Traded 06/12
Abraham CeesayCEO
Sell10b5-1 planRapport Therapeutics
Sell10b5-1 plan
Rapport Therapeutics
RAPP
$103.2K
3,552 sh
$103.2K
Filed 02/19
Traded 02/18

Abraham Ceesay, CEO — plans to sell 99,480 sh of Rapport Therapeutics RAPP · $4M · around 06/29 · 10b5-1 plan | Whalegun